Website

BlueOcean (BOV)

STO

Last updated: Jul 09, 2019

BlueOcean is a tokenized medtech VC fund.

IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Overview

Project industry	Health & Medicine
Product type	Service
Founded	Singapore
Whitepaper	Open

What is BlueOcean

The overall aim of medtech is to not only prevent disease and death but pre-empt and address new and existing conditions that are affecting human beings. Medtech is the union of the medical field, technology and large amounts of data that are being generated about patients and the diseases they exhibit. The medtech field covers both medical devices as well as in vitro (meaning: in the glass) diagnostic medical devices, processes and procedures.

Medtech covers a wide array of devices and applications including familiar, household goods such as syringes and spectacles through to high-tech applications such as molecular diagnostics and implantable devices such as heart valves. There is no living human that has not interacted with thousands of medtech devices over their lifetime or even on a daily basis.

According to the European Medical Technology Industry report of 2018, “There are more than 500,000 medical technologies currently available and they all share a common purpose: improving, extending and transforming people’s lives.”

BlueOcean Ventures is a Swiss venture capital firm specialized in investing in ventures from the medical field;

The BlueOcean Ventures General Partners have founded, invested in and exited numerous companies and have successfully held positions in strategy, finance and senior management in large corporations and startup companies. To date, the team has invested in 30+ companies of which several have been successfully exited and 9 have been financed through the team’s first fund BlueOcean Ventures I, since 2008;

BlueOcean Ventures II was launched in 2015, and is currently investing in Medtech and Life Science companies in Switzerland and the EU. The fund has currently US$ 10m (Fiat) under management and has invested in 5 portfolio companies.